IRIS

PORTA, Camillo Guglielmo Giuseppe

PORTA, Camillo Guglielmo Giuseppe  

DIPARTIMENTO INTERDISCIPLINARE DI MEDICINA  

Mostra records
Risultati 1 - 20 di 287 (tempo di esecuzione: 0.139 secondi).
Titolo Data di pubblicazione Autore(i) File
1101MO Development of CAR T-cells for future treatment of NETs 1-gen-2021 Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M.
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma] 1-gen-2015 Giglione, Palma; Lombardo, Fiorella; Toscani, Ilaria; Paglino, Chiara; Porta, Camillo
[The Treatment of Metastatic Renal Cell Carcinoma: An Update] 1-gen-2023 Pezzicoli, Gaetano; Ganini, Carlo; Re Sartò, Giulia Vanessa; Pirovano, Marta; Cosmai, Laura; Porta, Camillo
A Glimpse in the Future of Malignant Mesothelioma Treatment 1-gen-2021 Pezzicoli, G.; Rizzo, M.; Perrone, M.; Minei, S.; Mutti, L.; Porta, C.
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma 1-gen-2023 Mcgregor, Bradley; Geynisman, Daniel M; Burotto, Mauricio; Suárez, Cristina; Bourlon, Maria T; Barata, Pedro C; Gulati, Shuchi; Huo, Stephen; Ejzykowicz, Flavia; Blum, Steven I; Del Tejo, Viviana; Hamilton, Melissa; May, Jessica R; Du, Ella X; Wu, Aozhou; Kral, Pavol; Ivanescu, Cristina; Chin, Andi; Betts, Keith A; Lee, Chung-Han; Choueiri, Toni K; Cella, David; Porta, Camillo
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 1-gen-2021 Del Re, Marzia; Cucchiara, Federico; Rofi, Eleonora; Fontanelli, Lorenzo; Petrini, Iacopo; Gri, Nicole; Pasquini, Giulia; Rizzo, Mimma; Gabelloni, Michela; Belluomini, Lorenzo; Crucitta, Stefania; Ciampi, Raffaele; Frassoldati, Antonio; Neri, Emanuele; Porta, Camillo; Danesi, Romano
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer 1-gen-2015 Albiges, L.; Choueiri, T.; Escudier, B.; Galsky, M.; George, D.; Hofmann, F.; Lam, T.; Motzer, R.; Mulders, P.; Porta, C.; Powles, T.; Sternberg, C.; Bex, A.
Abemaciclib for malignant pleural mesothelioma 1-gen-2022 Nardone, Valerio; Porta, Camillo; Giannicola, Rocco; Correale, Pierpaolo; Mutti, Luciano
Abstract 2012: In vitro validation of tumor-derived large extracellular vesicles isolation and characterization as suitable tool for liquid biopsy 1-gen-2021 Pezzicoli, Gaetano; Lovero, Domenica; Tucci, Marco; Porta, Camillo; Mannavola, Francesco
Abstract 2808: Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model 1-gen-2021 Mannavola, Francesco; Lovero, Domenica; Felici, Claudia; Stucci, Luigia Stefania; Porta, Camillo; Tucci, Marco
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies 1-gen-2020 Cosmai, Laura; Porta, Camillo; Privitera, Carmelo; Gesualdo, Loreto; Procopio, Giuseppe; Gori, Stefania; Laghi, Andrea
Acute Kidney Injury in Cancer Patients 1-gen-2018 Gallieni, M.; Cosmai, L.; Porta, C.
Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review 1-gen-2023 Lauricella, Eleonora; Manicone, Anna; Cavallo, Federica; Dagrada, Gian Paolo; Centonze, Giovanni; Bertulli, Rossella; Quattrone, Pasquale; Porta, Camillo; Cives, Mauro
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 1-gen-2016 Massari, F.; Modena, A.; Ciccarese, C.; Pilotto, S.; Maines, F.; Bracarda, S.; Sperduti, I.; Giannarelli, D.; Carlini, P.; Santini, D.; Tortora, G.; Porta, C.; Bria, E.
Adjuvant therapy in renal cell carcinoma 1-gen-2017 Massari, F.; Di Nunno, V.; Ciccarese, C.; Graham, J.; Porta, C.; Comito, F.; Cubelli, M.; Iacovelli, R.; Heng, D. Y. C.
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 1-gen-2021 Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C.
Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes 1-gen-2015 Rothermundt, C.; Bailey, A.; Cerbone, L.; Eisen, T.; Escudier, B.; Gillessen, S.; Grunwald, V.; Larkin, J.; Mcdermott, D.; Oldenburg, J.; Porta, C.; Rini, B.; Schmidinger, M.; Sternberg, C.; Putora, P. M.
An anti-mica/b antibody and il-15 rescue altered nkg2d-dependent nk cell responses in hepatocellular carcinoma 1-gen-2020 Mantovani, S.; Varchetta, S.; Mele, D.; Donadon, M.; Torzilli, G.; Soldani, C.; Franceschini, B.; Porta, C.; Chiellino, S.; Pedrazzoli, P.; Santambrogio, R.; Barabino, M.; Cigala, C.; Piccolo, G.; Opocher, E.; Maestri, M.; Sangiovanni, A.; Bernuzzi, S.; Lhospice, F.; Kraiem, M.; Mondelli, M. U.; Oliviero, B.
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 1-gen-2020 Porta, C.; Giannatempo, P.; Rizzo, M.; Lucarelli, G.; Ditonno, P.; Battaglia, M.
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study 1-gen-2021 Mosca, Alessandra; De Giorgi, Ugo; Procopio, Giuseppe; Basso, Umberto; Cartenì, Giacomo; Bersanelli, Melissa; Naglieri, Emanuele; Galli, Luca; Caffo, Orazio; Fornarini, Giuseppe; Boccardo, Francesco; Porta, Camillo